Skip to content

Raptor Pharmaceutical Corp

CIK 0001070698

← back to feed
Revenue (TTM)
$94.24M
+35.6% YoY Q2 Aug 2016
Net Income (TTM)
−$84.14M
+216.4% YoY Q2 Aug 2016
EPS Diluted (TTM)
—
Q2 Aug 2016
Gross Margin
99.8%
Q2 Aug 2016
Operating Margin
-69.7%
Q2 Aug 2016
Net Margin
-89.3%
Q2 Aug 2016
Free Cash Flow (TTM)
−$52.47M
Q2 Aug 2016
Cash
$124.24M
Q2 Aug 2016
Total Debt
$45M
Q2 Aug 2016
Shares Outstanding
85.31M sh
Q2 Aug 2016

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings